Cargando…

Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI

Detalles Bibliográficos
Autores principales:	Marrone, Giuseppe, Galati, Francesco, Biolato, Marco, Oddy, Christopher, De Carolis, Sara, Zoli, Angelo, Grieco, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487132/ https://www.ncbi.nlm.nih.gov/pubmed/34598668 http://dx.doi.org/10.1186/s12876-021-01933-z

Ejemplares similares

Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI
por: Marrone, Giuseppe, et al.
Publicado: (2021)

Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach
por: Biolato, Marco, et al.
Publicado: (2017)

Upper Limits of Downstaging for Hepatocellular Carcinoma in Liver Transplantation
por: Biolato, Marco, et al.
Publicado: (2021)

A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series
por: Biolato, Marco, et al.
Publicado: (2022)

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia
por: Biolato, Marco, et al.
Publicado: (2022)

The Promise of AI for DILI Prediction
por: Vall, Andreu, et al.
Publicado: (2021)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016)

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
por: Uetrecht, Jack
Publicado: (2019)

Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis
por: Biolato, Marco, et al.
Publicado: (2019)

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties
por: Marrone, Giuseppe, et al.
Publicado: (2023)

The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
por: Biolato, Marco, et al.
Publicado: (2021)

Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
por: Stern, Sydney, et al.
Publicado: (2023)

Disseminated intravascular coagulation after splenic artery aneurysm coils embolization: an unexpected surprise
por: Biolato, Marco, et al.
Publicado: (2023)

Cytomegalovirus Infection May Trigger Adult-Onset Still's Disease Onset or Relapses
por: Jia, Jinchao, et al.
Publicado: (2019)

Factors limiting immunization coverage in urban Dili, Timor-Leste
por: Amin, Ruhul, et al.
Publicado: (2013)

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
por: Watkins, Paul B.
Publicado: (2019)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Landscape of DILI-related adverse drug reaction in China Mainland
por: Wang, Jiabo, et al.
Publicado: (2022)

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development
por: Regev, Arie, et al.
Publicado: (2014)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
por: Nicoletti, Alberto, et al.
Publicado: (2019)

Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients
por: Nociti, Viviana, et al.
Publicado: (2018)

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI
por: Woodhead, J L, et al.
Publicado: (2014)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
por: Tátrai, Péter, et al.
Publicado: (2022)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Treatment of mediastinitis following cardiac surgery-still in discussion
por: Ennker, I C
Publicado: (2013)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
por: Bessone, Fernando, et al.
Publicado: (2016)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
por: Liu, Anika, et al.
Publicado: (2021)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

DILI( C ): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
por: Rathee, Sanjay, et al.
Publicado: (2022)

Rebuttal to: A series of homeopathic remedies-related severe DILI from South India
por: Kaushik, Subhash, et al.
Publicado: (2023)

Beneficial Effect of Tacrolimus… Cyclosporin A, Still up for Discussion!
por: Ruiz, Isaac
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i2n4etrg60gun40s3qv1m36cd7